|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in pa- tients with type 2 diabetes mellitus inadequately con- trolled glimepiride alone or on glimepiride and mefformin 显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 2 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or in combination with metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 3 | Pioglitazone hydrochloride in combination with type 2 diabetes mellitus: a randomized, placebo-controlled study显示文摘 | KIPNES M S KROSNICK A RENDELL M S | 2001 | Am J Med2001，111，： | 1 |
| 4 | Effieaey and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in pa-tients with type 2 diabetes mellitus inadequately con- trolled on glimepiride alone or on glimepiride and met- formin显示文摘 | Hermansen K Kipnes M Luo E et d | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 5 | Safety and pharmacody- namics of CJC-1134-PC, a novel GLP-1 receptor agonist,in pa- tients with type 2 diabetes mellitus : a randomized, Placebo-Con-trolled ; Double-Blind, Dose-Escalation study 显示文摘 | Wang M Kipnes M Matheson S | 2007 | Diabetes2007，56，1： | 1 |
| 6 | Efficacy and safety of the dipel):tidylpeptidase-4 inhibitor,sitagliptin,inpatients with type 2 diabetes mellitue inadequately controlled on glimepiridealone or on glimepiride and metformin显示文摘 | Hermansen K Kipnes M Luo E et at | 2007 | DiabetesObesMetab2007，9，5： | 1 |
| 7 | Dapagliflozin: an emerging treatment option in type 2 diabetes显示文摘 | Kipnes M | 2009 | Expert Opin Investig Drugs2009，18，3： | 1 |
| 8 | Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus; a randomized, placebo - controlled study 显示文摘 | Kipnes M Krosnick A Rendell M | 2001 | Am J Med2001，111，： | 1 |
| 9 | Biological defense mechanisms:the production by leukocytes of superoxide,a potential bactericidal agent显示文摘 | Babior B M Kipnes R S Curnutte J T | 1973 | J Clin Invest1973，52，： | 1 |
| 10 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 11 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin显示文摘 | HERMANSEN K KIPNES M LUO E | | 0，，05： | 1 |
| 12 | Control of post-prandial plasma glucose by an oral insulin product(HIM2) in patients with type 2 diabetes显示文摘 | Kipnes M Dandona P Tripathy D | 2003 | Diabetes Care2003，26，2： | 1 |
| 13 | Sitagliptin: a review 显示文摘 | SUBBARAYAN S KIPNES M | 2011 | Exp Opln Pharm2011，12，10： | 1 |
| 14 | Control of postprandial plasma glucose by an oral insulin product(HIM2) in patients with type 2 diabetes显示文摘 | Kipnes M Dandona P Tripathy D | 2003 | Diabetes Care2003，26，2： | 1 |
| 15 | Dapaglifozin: an emergingtreatmentoptionin type 2 diabetes 显示文摘 | Kipnes M | 2009 | Expert Opin Investig Drugs2009，18，3： | 1 |
| 16 | Efficacy and safety ofthe dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients withtype 2 diabetes mellitus inadequately controlled on glimepiride a-lone or on glimepiride and metformin 显示文摘 | Hermansen K Kipnes M Luo E | | Diabetes Obes Metab0，，： | 1 |
| 17 | Biological defense mechanisms:the production by leukocytes of superoxide, a potential bactericidal agent显示文摘 | Babior B M Kipnes R S Curnutte J T | 1973 | The Journal of Clinical Investigation1973，52，3： | 1 |
| 18 | Efficacy and safety of thedipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type2 diabetes mellitus inadequately controlled on glimepiride alone oron glimepiride and metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 19 | Dapaglifozin: an emergingtreatmentoptionin type 2 diabetes显示文摘 | KIPNES M | 2009 | Expert Opin Investig Drugs2009，18，3： | 1 |
| 20 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled glimepiride alone or on glimepiride and metformin 显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员